Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1295-1306
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1295
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1295
Table 3 Multivariate analyses of risk factors affecting overall survival in total patients, n = 144
| Characteristics | HR (95%CI) | P value | |
| Tumor size in cm | < 5 | 1 | 0.027 |
| ≥ 5 | 1.78 (1.07-2.95) | ||
| Histological grade | High | 1 | 0.011 |
| Low | 2.25 (1.21-4.18) | ||
| TNM stage | Ⅰ + Ⅱ | 1 | < 0.001 |
| Ⅲ | 2.84 (1.72-4.70) | ||
| 5-hmC | Low | 1 | 0.040 |
| High | 0.61 (0.38-0.98) |
- Citation: Fu YL, Wu YH, Cao DH, Jia ZF, Shen A, Jiang J, Cao XY. Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients. World J Gastrointest Oncol 2022; 14(7): 1295-1306
- URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1295.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1295